U.S. Markets close in 1 hr 18 mins

Merck upgraded to Outperform following recent pullback at BMO Capital

BMO Capital upgraded Merck to Outperform from Market Perform on the belief that shares are near a bottom. BMO says consensus estimates have come down and that a number of new data catalysts could move shares higher. The firm upped its price target for the stock to $50 from $48.